Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of cytoreductive surgery in the management of progressive glioblastoma in adults.
Publication/Presentation Date
6-1-2022
Abstract
QUESTION: In patients with previously diagnosed glioblastoma who are suspected of experiencing progression, does repeat cytoreductive surgery improve progression free survival or overall survival compared to alternative interventions?
TARGET POPULATION: These recommendations apply to adults with previously diagnosed glioblastoma who are suspected of experiencing progression of the neoplastic process and are amenable to surgical resection.
RECOMMENDATION: Level II: Repeat cytoreductive surgery is recommended in progressive glioblastoma patients to improve overall survival.
Volume
158
Issue
2
First Page
167
Last Page
177
ISSN
1573-7373
Published In/Presented At
Patrick, H. H., Sherman, J. H., Elder, J. B., & Olson, J. J. (2022). Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of cytoreductive surgery in the management of progressive glioblastoma in adults. Journal of neuro-oncology, 158(2), 167–177. https://doi.org/10.1007/s11060-021-03881-w
Disciplines
Medicine and Health Sciences
PubMedID
35246769
Department(s)
Fellows and Residents
Document Type
Article